FdaApplication

ANDA 203574

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeANDA
approval_date2018-11-20

Products (1)

ProductActive ingredientStrengthDosage form
MESALAMINEMESALAMINE1.2GMTABLET, DELAYED RELEASE;ORAL

1 product